MedTrace Logo

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

NCT07039149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-28

No results posted yet for this study

Summary

This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?

Conditions

  • Major Bleeding
  • Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)

Sponsors & Collaborators

  • Jordan Collaborating Cardiology Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2026-08-01
Completion
2026-11-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07039149 on ClinicalTrials.gov